P29: EFFECTS OF VACCINATION ON INCIDENCE AND OUTCOME OF SARS-COV-2 INFECTION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)

por Sgherza, N, Rizzi, R, Curci, P, Roccotelli, D, Croce, M, Avantaggiato, M, Ruga, L, Musto, P
Publicado 2022

P63 BREAKTHROUGH COVID-19 IN FULL VACCINATED PATIENTS WITH MULTIPLE MYELOMA: A SINGLE CENTER EXPERIENCE OF 54 PATIENTS

por Sgherza, N., Curci, P., Rizzi, R., Perfetto, A., Battisti, O., Pizzileo, N., De Trizio, G., Musto, P.
Publicado 2023

Potential of Stem Cell-Based Therapy for Ischemic Stroke

por Marei, Hany E., Hasan, A., Rizzi, R., Althani, A., Afifi, N., Cenciarelli, C., Caceci, Thomas, Shuaib, Ashfaq
Publicado 2018

Surface functionalization of acrylic based photocrosslinkable resin for 3D printing applications

por Ronca, A., Maiullari, F., Milan, M., Pace, V., Gloria, A., Rizzi, R., De Santis, R., Ambrosio, L.
Publicado 2017

PlGF–MMP9-engineered iPS cells supported on a PEG–fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium

por Bearzi, C, Gargioli, C, Baci, D, Fortunato, O, Shapira-Schweitzer, K, Kossover, O, Latronico, M V G, Seliktar, D, Condorelli, G, Rizzi, R
Publicado 2014

P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)

por Sgherza, N., Curci, P., Rizzi, R., Roccotelli, D., Croce, M., Avantaggiato, M., Ruga, L., Vitucci, A., Palma, A., Di Gennaro, D., Musto, P.
Publicado 2022

Myeloma cells suppress osteoblasts through sclerostin secretion

por Colucci, S, Brunetti, G, Oranger, A, Mori, G, Sardone, F, Specchia, G, Rinaldi, E, Curci, P, Liso, V, Passeri, G, Zallone, A, Rizzi, R, Grano, M
Publicado 2011

Post-natal cardiomyocytes can generate iPS cells with an enhanced capacity toward cardiomyogenic re-differentation

por Rizzi, R, Di Pasquale, E, Portararo, P, Papait, R, Cattaneo, P, Latronico, M V G, Altomare, C, Sala, L, Zaza, A, Hirsch, E, Naldini, L, Condorelli, G, Bearzi, C
Publicado 2012

P39 DEDALO: PHASE II STUDY OF DARATUMUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE (DPD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND 17P DELETION

por Montefusco, V., Cafro, A.M., Margiotta Casaluci, G., Patriarca, F., Mina, R., D’Agostino, M., Capra, A., Priola, C., Dalla Palma, B., Rizzi, R., Genua, A., Petrucci, M.T., Paris, L., Belotti, A., Cavo, M., Conticello, C., Carlo-Stella, C., Boccadoro, M
Publicado 2023